Oklo CPO Renner sells $41,129 in stock after RSU vesting

Alexandra Renner, Chief Product Officer of Oklo Inc. (NASDAQ:OKLO), disposed of 1,100 shares of the company’s Class A Common Stock for a total value of $41,129, according to a recent SEC filing. The transaction occurred on September 28, 2026, with shares sold at a price of $37.39 each.

The sale was conducted to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (RSUs) and did not represent a discretionary transaction by Ms. Renner.The transaction comes as Oklo shares have declined sharply, currently trading at $26.35, down nearly 30% from Ms. Renner’s sale price and hovering near the 52-week low of $26.07. According to InvestingPro analysis, which offers comprehensive insights on over 1,400 US equities including detailed Pro Research Reports, the stock has fallen over 80% in the past year.

Two days prior, on September 26, 2026, Ms. Renner acquired 2,471 shares of Class A Common Stock. These shares resulted from the full vesting of 2,471 RSUs that were granted to her on November 4, 2025. Each RSU represents a contingent right to receive one share of Oklo’s Class A Common Stock.

Following these transactions, Ms. Renner directly holds 477,595 shares of Class A Common Stock. Additionally, she indirectly holds 116,390 shares through a joint account with her spouse.

In other recent news, Oklo Inc. has been the subject of several analyst updates. Piper Sandler lowered its price target for Oklo to $49 from $55, citing higher capital expenditure estimates for new plants. Despite this adjustment, the firm maintained its Overweight rating on the stock. Canaccord Genuity reiterated a Buy rating with a $100 price target, highlighting the potential growth in Oklo’s isotope division as Groves-2 advances. Additionally, Piper Sandler reaffirmed its confidence in Oklo’s reactor progress at the Groves facility, maintaining an Overweight rating and a $55 price target. Truist Securities reiterated a Hold rating with a $51 price target, noting ongoing development activities across Oklo’s Power, Fuel, and Isotope segments. Meanwhile, UBS adjusted its price target to $41 from $55, maintaining a Neutral rating, after updating its estimates to reflect increased administrative expenses and reduced long-term R&D spending. These developments provide investors with a range of insights into Oklo’s financial and operational strategies.